JOURNAL OF BUON, vol.25, no.1, pp.268-273, 2020 (SCI-Expanded)
Article / Article
JOURNAL OF BUON
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
lung cancer, NSCLC, immunotherapy, PD-1, PD-L1, DEATH-LIGAND 1, PROGNOSTIC-FACTOR, PULMONARY ADENOCARCINOMA, CLINICAL-SIGNIFICANCE, PROTEIN EXPRESSION, DOCETAXEL, STATISTICS, MUTATIONS, NIVOLUMAB
Gazi University Affiliated:
Purpose: There are conflicting results in the literature about the relationship between PD-1/PD-L1 expression and prognosis in non-small cell lung cancer (NSCLC). The purpose of this study was to identify the relationship between NSCLC patients' clinicopathologic characteristics and PD-1/PD-L1 expression.